will tirzepatide go back on the shortage list GLP-1 Weight-Loss Drugs Off List; Deadlines to Stop Compounding FDA Removes Tirzepatide from Shortage

Always click the cap back on firmly after your dose

Edibles Consuming cannabis in edible form allows for a slower and more controlled release into the bloodstream

Practical Guidance: Starting Mounjaro on a Blood Thinner Heres what a sensible clinical approach looks like: Tell your prescriber

The global GLP-1 diabetes treatment drugs market is estimated to be valued at USD 6,556.5 million in 2025

In another cohort study based on 280,090 term infants born at Kaiser Permanente hospitals in northern California between 2011 and 2019, 7,573 (2.7%) infants that had been exposed to SSRIs in late pregnancy, and 11.2% experienced delayed adaptation (defined as a 5-min Apgar score 5, resuscitation at birth, or the administration of respiratory support owing to admission to the neonatal intensive care unit), compared with 4.4% in the unexposed group

Let us start with the good news